Literature DB >> 20348426

Caspases in virus-infected cells contribute to recognition by CD8+ T lymphocytes.

Daniel López1, Margarita García-Calvo, Geoffrey L Smith, Margarita Del Val.   

Abstract

CD8(+) cytotoxic T lymphocytes recognize infected cells in which MHC class I molecules present pathogen-derived peptides that have been processed mainly by proteasomes. Many infections induce a set of proteases, the caspases involved in apoptosis or inflammation. In this study, we report that processing and presentation of a short vaccinia virus-encoded Ag can take place also by a nonproteasomal pathway, which was blocked in infected cells with chemical inhibitors of caspases. By cleaving at noncanonical sites, at least two caspases generated antigenic peptides recognized by T lymphocytes. The sites and the peptidic products were partially overlapping but different to those used and produced by proteasomes in vitro. Antigenic natural peptides produced in infected cells by either pathway were quantitatively and qualitatively similar. Finally, coexpression of the natural vaccinia virus protein B13, which is an inhibitor of caspases and apoptosis, impaired Ag presentation by the caspase pathway in infected cells. These data support the hypothesis that numerous cellular proteolytic systems, including those induced during infection, such as caspases involved in apoptosis or in inflammation, contribute to the repertoire of presented peptides, thereby facilitating immunosurveillance.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20348426      PMCID: PMC4202692          DOI: 10.4049/jimmunol.1000050

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Mass spectrometric and chemical stability of the Asp-Pro bond in herpes simplex virus epitope peptides compared with X-Pro bonds of related sequences.

Authors:  Zsolt Skribanek; Gábor Mezo; Marianna Mák; Ferenc Hudecz
Journal:  J Pept Sci       Date:  2002-08       Impact factor: 1.905

2.  HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.

Authors:  M L Wei; P Cresswell
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

3.  Need for tripeptidyl-peptidase II in major histocompatibility complex class I viral antigen processing when proteasomes are detrimental.

Authors:  Sara Guil; Marta Rodríguez-Castro; Francisco Aguilar; Eugenia M Villasevil; Luis C Antón; Margarita Del Val
Journal:  J Biol Chem       Date:  2006-11-06       Impact factor: 5.157

Review 4.  Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.

Authors:  Carolina Johnstone; Margarita Del Val
Journal:  Traffic       Date:  2007-09-06       Impact factor: 6.215

5.  Differential effects of flanking residues on presentation of epitopes from chimeric peptides.

Authors:  C C Bergmann; L Tong; R Cua; J Sensintaffar; S Stohlman
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

6.  Selective involvement of proteasomes and cysteine proteases in MHC class I antigen presentation.

Authors:  D López; M Del Val
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

Review 7.  Proteasome and peptidase function in MHC-class-I-mediated antigen presentation.

Authors:  Peter Michael Kloetzel; Ferry Ossendorp
Journal:  Curr Opin Immunol       Date:  2004-02       Impact factor: 7.486

8.  Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89.

Authors:  M Del Val; H Volkmer; J B Rothbard; S Jonjić; M Messerle; J Schickedanz; M J Reddehase; U H Koszinowski
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

9.  An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL.

Authors:  S A Hammond; R P Johnson; S A Kalams; B D Walker; M Takiguchi; J T Safrit; R A Koup; R F Siliciano
Journal:  J Immunol       Date:  1995-06-01       Impact factor: 5.422

10.  An endogenous HIV envelope-derived peptide without the terminal NH3+ group anchor is physiologically presented by major histocompatibility complex class I molecules.

Authors:  Yolanda Samino; Daniel Lopez; Sara Guil; Patricia de León; Margarita Del Val
Journal:  J Biol Chem       Date:  2003-10-28       Impact factor: 5.157

View more
  8 in total

1.  Concerted antigen processing of a short viral antigen by human caspase-5 and -10.

Authors:  Daniel López; Mercedes Jiménez; Margarita García-Calvo; Margarita Del Val
Journal:  J Biol Chem       Date:  2011-03-28       Impact factor: 5.157

2.  Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.

Authors:  Elena Lorente; Ruth García; Daniel López
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

3.  Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.

Authors:  Elena Lorente; Ruth García; Carmen Mir; Alejandro Barriga; François A Lemonnier; Manuel Ramos; Daniel López
Journal:  J Biol Chem       Date:  2012-02-01       Impact factor: 5.157

Review 4.  Post-proteasomal and proteasome-independent generation of MHC class I ligands.

Authors:  Peter van Endert
Journal:  Cell Mol Life Sci       Date:  2011-03-10       Impact factor: 9.261

5.  Polyfunctional type-1, -2, and -17 CD8⁺ T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection.

Authors:  Debora Franceschini; Paola Del Porto; Silvia Piconese; Emanuele Trella; Daniele Accapezzato; Marino Paroli; Stefania Morrone; Enza Piccolella; Enea Spada; Alfonso Mele; John Sidney; Alessandro Sette; Vincenzo Barnaba
Journal:  PLoS Pathog       Date:  2012-06-21       Impact factor: 6.823

6.  Engineering of double recombinant vaccinia virus with enhanced oncolytic potential for solid tumor virotherapy.

Authors:  Galina Kochneva; Galina Sivolobova; Anastasiya Tkacheva; Antonina Grazhdantseva; Olga Troitskaya; Anna Nushtaeva; Anastasiya Tkachenko; Elena Kuligina; Vladimir Richter; Olga Koval
Journal:  Oncotarget       Date:  2016-11-08

7.  Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis.

Authors:  Francesco Lolli; Helene Martini; Alessandra Citro; Debora Franceschini; Emilio Portaccio; Maria Pia Amato; Rosella Mechelli; Viviana Annibali; John Sidney; Alessandro Sette; Marco Salvetti; Vincenzo Barnaba
Journal:  J Neuroinflammation       Date:  2013-07-27       Impact factor: 8.322

8.  Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases.

Authors:  Elena Lorente; Alejandro Barriga; Carolina Johnstone; Carmen Mir; Mercedes Jiménez; Daniel López
Journal:  PLoS One       Date:  2013-11-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.